NewMarket Corporation (NEU)

Investment Committee Summary

Investment Thesis

NewMarket is a petroleum additives business — a specialty chemicals franchise selling formulated additive packages whose value sits in formulation, customer qualification and switching cost rather than in volume. That is why the engine models an operating margin near 14% on a modest capital base, with net debt of ~$0.9B. At $868 on 9 September 2026 the shares are trading rich to the engine's triangulated fair value (-21%), at roughly 25 times forward earnings — a full multiple for a business whose volumes track industrial and transport activity rather than any secular growth driver. The price is discounting pricing-led compounding continuing indefinitely, and the engine's SELL is a statement about that multiple, not about the quality of the franchise. The variable that decides is the raw-material spread: additive pricing is sticky and input costs are not, so margin expands when feedstocks deflate and is given back when they inflate. The most damaging risk is that the current margin is the spread rather than the franchise — in which case the market is capitalising an input-cost windfall at a quality multiple, and normalisation cuts earnings and the multiple together.

Narrative drafted 2026-08-16 by claude-opus-5 under supervision; reviewed by Marinus 2026-08-16.

The dashboard below is the whole argument on one page: spot ($868) against each valuation anchor, the scenario tree, technicals and the options-implied move.

Anti-Thesis (The Real Bear Case)

The bear mechanism is spread compression and volume loss arriving together. Additive demand is derived from industrial and transport activity; in a downturn volumes fall while customers use the slack to reopen price, and a formulation business that has been earning an operating margin near 14% on favourable input costs discovers how much of that margin was the spread. Feedstock inflation does the same damage without a recession. Because the shares trade at roughly 25 times forward earnings, the de-rate compounds the earnings cut rather than cushioning it, and the engine's structural branch — brand and volume erosion — prices below the 52-week low. One model caveat belongs in the open: the engine's own probability of fair value clearing the current quote sits below its plausible band, which means the bear weighting here is aggressive and this downside distribution should be read as a stress case rather than a central expectation.

Key Debate

Gross Margin explains 53% of Monte Carlo outcome variance — the single variable that decides which side is right.

What the Market Is Pricing In

The house DCF sits 31% below spot, so the market is pricing in more than the house case — roughly 3.5pp of revenue CAGR.

Variant perception: the house view is above-consensus, and the thesis is primarily multiple-driven.

Scenario Analysis

The scenario tree spans a structural 'Structural — Brand / Volume Erosion' downside ($342) to a 'Bull — Cycle + Re-Rate' bull case ($1,412); the probability-weighted blend (PWEV $796) is -8% versus spot.

Share-count charge: none applied. The probability-weighted value above is the gross per-share figure — no annual dilution is deducted — free cash flow net of SBC is $0.49B. SBC is therefore disclosed, not charged: read the per-share figures as before dilution.

Scenario rationale — the driver path behind every target:

• Structural — Brand / Volume Erosion (20%, $342). Structural impairment — raw-material squeeze / volume loss: earnings AND the multiple compress together. Target sits below the 52-week low by construction.
• Downturn — Construction / Industrial Slump (18%, $596). Cyclical downturn — specialty volumes + price/raw-material spread + specification lock-in weakens for 1–2 years before normalising.
• Base — Pricing-Led Compounding (33%, $828). Mid-cycle — normalised specialty volumes + price/raw-material spread + specification lock-in; disciplined capital allocation; steady returns.
• Growth — Share Gains + Mix (21%, $1,118). Upside — share gains + input deflation lifts earnings above mid-cycle; the multiple expands modestly.
• Bull — Cycle + Re-Rate (8%, $1,412). Upside tail — sustained tight conditions or a structural re-rate on share gains + input deflation.

Valuation Triangulation

Three weighted anchors — an intrinsic dcf, a scenario-weighted pwev and a monte carlo median (student-t + regime switching) — read them with their basis in mind. The Monte Carlo, the DCF terminal and any peer re-rate key off a market multiple, so they are not fully independent; only discounted cash flows themselves are genuinely multiple-free. The discipline is to read the spread and weight the cash-based view, not to treat three numbers as three independent votes.

The house blend DECLARES five anchor weights — DCF 35%, scenario PWEV 25%, Monte Carlo 15%, sum-of-parts 15%, peer re-rate 10%. For this name sum-of-parts, peer P/E re-rate are not computed, so 25% of the declared weight is redistributed across the anchors that exist — which is why the weights above differ from the declared ones. The fair value is unaffected by this disclosure; the blend has always worked this way.

Peer EV/Revenue re-rate — 0% weight: it duplicates the peer-multiple information already carried by the Peer P/E anchor while ignoring margin mix; weighting both would double-count the peer view. Shown as a cross-check.

Monte Carlo — the outcome distribution

10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $707 and 33% of paths finish above spot. The variance decomposition shows the gross margin is the dominant swing factor (53% of variance). The fundamental driver, not the multiple, sets the spread — a cleaner setup.

DCF — the cash-flow anchor

Independent of the market multiple: a 5-year path, WACC 8.5%, 20.0x terminal FCF multiple → $602. This anchor is deliberately the heaviest (47%): it is the valuation least hostage to the current multiple regime.

Peer benchmarking — relative value

Against the peer cohort, re-rating to the peer-median EV/Revenue multiple implies $484; the peer-median forward P/E is 18.2x, but the engine carries no P/E-implied price for this name (no forward-EPS basis at the peer step). A premium is only justified by superior growth/margins; otherwise it is multiple risk. Excluded from the weighted blend — shown only as a market cross-check.

Across all anchors the spread is 44% of the median — wide (genuine disagreement — the blend carries low valuation confidence).

Sensitivity

DCF/share — WACC × terminal multiple

DCF/share — revenue CAGR Δ × op-margin Δ

Tornado — DCF/share swing by driver (widest first)

Company lever — SoP/share vs Specialty Chemicals & Formulated Materials multiple (AI re-rating) (base 23.0x)

Peer Quality & Weighting

Quality-weighted forward P/E: 18.5× (simple median 18.2×). Direct peers count 100%, segment 50%, broad 25%.

Historical-range cross-check: 52-week range $575–$962, centre $744 (-14% vs spot); spot sits at the 76th percentile of the range. Low-weight mean-reversion cross-check, not a fundamental anchor.

Risk / Reward & Margin of Safety

That ratio compares triangulated upside against the probability-weighted bear target, not the extreme tail; with a leg missing it is withheld rather than computed from a magnitude. Bull case (Bull — Cycle + Re-Rate): $1,412.

Company Overview & Business Model

NewMarket Corporation — BASIC MATERIALS · SPECIALTY CHEMICALS. NewMarket Corporation participates in the petroleum additives business. The company is headquartered in Richmond, Virginia.

How it makes money.

Edge. Wide moat — inferred from a 14% operating margin and the specialty chemicals / coatings business model. Durable pricing power supports a terminal multiple above the market.

Revenue-Segment Breakdown

The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)

Named Exposures

Demand & pricing cycle (FACT/ESTIMATE)

Capital intensity & shareholder returns (ESTIMATE)

Structural risk vs optionality (INFERENCE)

Industry Context — Materials — Quality

This name sits in the Materials — Quality cluster as a specialty chemicals & formulated materials name. coatings/specialty volumes + raw-material spread + pricing power. Its scenarios are not guessed in isolation — they inherit a single, shared view of the cluster's driver cycle, so the names that depend on the same event are mutually consistent.

Value chain: RPM (specialty chemicals & formulated materials) · WLK (specialty chemicals & formulated materials) · SOLS (specialty chemicals & formulated materials) · NEU (specialty chemicals & formulated materials) · AXTA (specialty chemicals & formulated materials) · AVNT (specialty chemicals & formulated materials)

Mapping note: name-level 'Structural — Brand / Volume Erosion' (20%) + 'Downturn — Construction / Industrial Slump' (18%) map to cluster Industrial Recession — Demand / De-Rate (38%); name-level 'Growth — Share Gains + Mix' (21%) + 'Bull — Cycle + Re-Rate' (8%) map to cluster Expansion — Volume + Pricing Upside (29%) — the cluster row is the SUM of the mapped scenario probabilities, not a different estimate.

On the cluster's key downside — Industrial Recession — Demand / De-Rate — this name implies 38% vs the cluster house view of 38% (in line with the house). The cluster's full cross-stock reconciliation governs that the names which ride the same capex cycle assign it comparable odds.

Structure: Shared State — The quality cycle is the shared macro driver. Driver — global industrial demand + pricing power (gases, coatings, specialty/ag). Dispersion — Members differ by cyclicality (quality compounders vs deep cyclicals).

Balance Sheet & Liquidity

Balance-sheet data as of 2025-12-31 (Alpha Vantage).

Capital Allocation

Free-Cash-Flow Quality

Accounting quality: SBC 1% of revenue; cash conversion (OCF/NI) 136% — cash-backed.

Earnings-Call Disconfirmation & Sentiment

Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.

News (last 365d, 165 articles): avg ticker sentiment +0.16 (bullish 28% / bearish 2%)

Consensus & Market Expectations

_Consensus figures: Alpha Vantage sell-side aggregates. Where the house view sits materially above or below the street, the divergence is itself a datum — see the thesis.

Catalyst Calendar

• 2026-10-29 (~51d) — Quarterly earnings (AV EARNINGS_CALENDAR)

Forecast Track Record

• EPS surprise: beat 50% of the last 4 quarters; average surprise +0.0%.
• Prior-forecast backtest (19 snapshots, 2026-07-21→2026-09-03): directional hit-rate 90%; mean predicted -10.0% vs realised -1.9%. Disconfirming track record is reported, not suppressed.

Catalyst Timeline

6 catalysts in the next 90 days (of 14 tracked). Importance 1–3; confidence 0–1.

_Sources: extended.catalysts, data/catalysts/.json, data/catalysts/macro.json, AV DIVIDENDS, opex 3rd-Friday calc.

Scenario Macro & Key Risks

Decision Rules (Machine-Checked)

Stance: Hold — 0 bullish / 0 bearish / 0 caution rules triggered of 5 evaluable (1 lacked data).

Machine-checked rules over disclosed inputs. The authored falsification triggers elsewhere in this report are analyst judgment and are NOT evaluated here. The stance is a portfolio-management signal and does not modify the published research rating.

Reasons the Thesis Could Fail (Falsifiable)

Pre-registered signals that would break the thesis — each polices a specific scenario boundary and is checked at every earnings update:

• Organic revenue growth / order backlog < flat-to-negative for two consecutive quarters (2 consecutive prints). Sustained demand rollover breaks the base case toward the recession scenario.
• FY revenue ($B) < 2.75 (next reported fiscal year). (rationale withheld pending re-authoring — frozen figure or verdict)
• Probability-weighted fair value (PWEV) at the next re-run < 867.7 (any scheduled re-run). (rationale withheld pending re-authoring — frozen figure or verdict)

Fact / Inference / Speculation

• FACT: Spot $868; 52-week range $575–$962; engine rating SELL; house target $796 (-8%). (source: Alpha Vantage 2026-09-08, 9 September 2026)
• INFERENCE: Triangulated FV $688 (-21% vs spot · triangulated FV); the rating tracks the Monte-Carlo + scenario-PWEV core; the cash-flow anchor sits below the multiple-discipline core.
• SPECULATION: At current prices the embedded bet is that Gross Margin keeps surprising favourably — an operating call the next two prints will test.

Conviction Score

Research Conviction measures the strength and quality of the research setup — input coverage, financial quality, valuation support, process agreement. It is NOT the probability that the recommendation succeeds; the forecast track record section is the evidence on that.

57.4/100 (confidence band 49.4–65.4), 46th percentile of 893 covered names (as of 2026-09-08). Weighted composite under config ros-1.20.0 — every component and its inputs below.

Score history: 58.1 → 57.8 → 57.8 → 57.7 → 57.1 → 57.3 → 57.1 → 57.1.

Probability-Weighted Return Profile

Horizon: 1 year — at this horizon CAGR equals total return by definition. Expected values are the probability-weighted sums over the full scenario set below.

The gross expected return is the probability-weighted scenario return (it reconciles to the gross PWEV); the diluted figure applies the SBC share-count charge and matches the published PWEV-based target.

Expected Alpha

Expected return minus the return this name is REQUIRED to deliver for its risk (1-year horizon). Constants are pre-registered (preregistered-static (amendment #2, 2026-07-29); not fitted to MCH outcomes).

A negative expected alpha does not change the rating — it says the expected return does not clear the risk-adjusted hurdle at today's price. Rating mechanics are unchanged by this section.

Probability Cross-Checks

Not authoritative. The scenario probabilities in this report are AUTHORED — a judgement about how the world might go, not a measurement. Nothing below modifies them, the target, the rating or any position size. These checks ask only whether anything outside our own model agrees with us; where it does not, that is information for the reader, not a correction we have quietly applied.

Authored set: 5 scenarios, probabilities summing to 1.0, mean target $796.49.

Factor Exposures

Cross-sectional percentiles over 893 covered names (style scores sector-demeaned; thematic = return-beta to the theme's proxy ETF). 50 = estate median.

Market interaction: correlation vs SPY +0.32, vs QQQ +0.25 (trailing ~1y daily returns).

Options Intelligence

Preferred structure: Put Debit Spread. The selector reads the equity view (direction) and the volatility surface — nothing here re-prices the chain.

• bearish with cheap options — buy defined-risk downside
• Direction bearish from the overlay conviction/rating (read-only input).
• IV/RV at the 29th percentile of the cross-section → low vol bucket. This is the measure that selects the structure above: it ranks how rich this name's implied vol is against its own realised vol, relative to other names.
• Reported alongside and not used to select: this name's own ATM IV sits at the 88th percentile of its own month-end history (decile 9). The two measures disagree here — vol is high for this name by its own history while its options are not unusually rich against its realised vol. Where they diverge, the cross-sectional measure is the one acting.
• IV term structure is in contango (longer-dated richer, slope +2.9pp) — favour longer-dated ownership (LEAPS) or calendars that are long the cheaper front.
• No live-chain Put Debit Spread was priced for this name — shown as the indicated strategy; size against a freshly pulled chain.

IV term structure (contango, slope +2.9pp): 38-DTE 30% · 101-DTE 32% · 192-DTE 33%

No live-chain Put Debit Spread was priced for this name — shown as the indicated approach; size against a fresh chain.

Alternatives: Protective Put. IV rank shown via the name's own monthly IV history (advisory); structure selected on the cross-sectional IV/RV percentile. Model output for research and education only — not individualised investment advice. Position-sizing and stance figures are mechanical outputs of the disclosed rules and inputs; they do not consider any person's objectives, financial situation, or tax status.

Position Sizing Framework

research rating is SELL-tier — the model carries no long position.

Model output for research and education only — not individualised investment advice. Position-sizing and stance figures are mechanical outputs of the disclosed rules and inputs; they do not consider any person's objectives, financial situation, or tax status.

Options Overlay

A defined-risk way to express the SELL equity view. Chain as of 2026-09-08 — end-of-day marks — indicative, not executable quotes.

Market signals — ATM IV 29.8% (moderate regime) · expected move ±7.6% (2026-10-16) · put/call OI 0.08 · ATM Δ 0.52 / Θ -0.45 / ν 1.11 · next earnings 2026-10-29. Direction: NEUTRAL (implied return -20.7% to triangulated fair value $687.69).

Covered Call (if held) (Income / neutral) — Short 930 C · 2026-10-16 · premium $10.9 · yield 1.3% · priced from the listed chain (EOD marks)

Converts a near-fair holding into income by agreeing to sell at a higher strike — worth weighing when upside looks limited near fair value and being called away is acceptable. Illustrative — no outcome is implied or guaranteed.

Put Spread (income) (Income / would-own) — Short 800 P / Long 740 P · 2026-10-16 · net $9.89 · net entry $790.11 · yield 1.2% · RoR 20.0% · max loss $50.11 · priced from the listed chain (EOD marks)

Gets paid to wait for a lower entry, with the tail capped: the sold put collects premium while the cheaper long wing below it caps the maximum loss at the spread width — a defined-risk alternative to a naked cash-secured put.

Protective Collar (if held) (Hedge) — Long 780 P / Short 960 C · 2027-03-19 · net $9.4 · floor -10.0% · cap +11.0% · priced from the listed chain (EOD marks)

For a holder who wants to stay invested but cap risk: the sold call funds most of the protective put, fencing the position into a band — a way to ride out a de-rating without selling.

Indicative options structures — a defined-risk expression of the equity view, model-and-market illustrated from the last-close chain. NOT personalised advice or an executable quote; premiums, IV and greeks move intraday. Options carry the risk of total loss of premium. Not a registered financial adviser.

Rating Bridge

Rating = SELL because:

• Probability-weighted scenario value implies -8% vs spot
• Monte Carlo median implies -18% vs spot
• DCF fair value implies -31% vs spot
• Bear case (Structural — Brand / Volume Erosion) downside is -61% vs spot
• Net: the valuation anchor itself sits 20.7% below spot, so there is no reward leg to weigh against the bear case and the reward-to-risk ratio is withheld rather than computed off a negative upside. The rating warrants a Sell.

Model Appendix

DCF — line items

FCF is bridged: NOPAT + D&A − Capex − ΔNWC (capex intensity 4% of revenue, weighted from the segments) — not a single conversion fudge.

WACC 8.5% · Σ PV(FCF) $1B + PV(terminal) $5B = EV $6B; − net debt $0.9B → equity $5B ÷ diluted shares $0.01B = $602/share (exit-multiple terminal).

• Gordon terminal at 2.5% → $521/share — a genuinely non-multiple, cash-based cross-check; the exit-multiple and Gordon values bracket the terminal-value risk.
• Incremental ROIC on the forecast capex ≈ 12% vs WACC 8.5% → above WACC — the build is value-creative.

Peer set

Implied prices at the peer medians: EV/Rev → $484 (no P/E-implied price — no forward-EPS basis at the peer step).

Weighted fair-value math

Assumption Register

Sensitivity-ranked drivers (widest fair-value swing first): Op margin ±3pp (287.0); Terminal × ±15% (167.0); Revenue CAGR ±3pp (159.0); Capex intensity ±15% (75.0); WACC ±1pp (59.0).

Inputs, Sources & Confidence

Every load-bearing input, labelled by type and confidence. (reported fact · company guidance · consensus estimate · market data · house estimate · inference.)

Research Provenance

Load-Bearing Assumptions

DCF: WACC 8.5%, terminal multiple 20×, FY+5 revenue $3B. Triangulation leans 47% on DCF, 33% on PWEV, 20% on the Monte Carlo median.